BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 16368476)

  • 21. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
    Schmitz FJ; Fluit AC; Gondolf M; Beyrau R; Lindenlauf E; Verhoef J; Heinz HP; Jones ME
    J Antimicrob Chemother; 1999 Feb; 43(2):253-9. PubMed ID: 11252331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. United States resistance surveillance results for linezolid (LEADER Program for 2007).
    Jones RN; Ross JE; Castanheira M; Mendes RE
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):416-26. PubMed ID: 19022153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Pfaller MA; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):63-8. PubMed ID: 16650951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiology of acute otitis externa.
    Roland PS; Stroman DW
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1166-77. PubMed ID: 12169893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic Resistance Among Ocular Pathogens in the United States: Five-Year Results From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.
    Asbell PA; Sanfilippo CM; Pillar CM; DeCory HH; Sahm DF; Morris TW
    JAMA Ophthalmol; 2015 Dec; 133(12):1445-54. PubMed ID: 26502312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility patterns of bacterial isolates from intensive care and haematology/oncology patients in New Zealand.
    Morris AJ; Bremmer DA; Jones MR; Schousboe MI
    N Z Med J; 1997 May; 110(1044):187-9. PubMed ID: 9201205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo.
    Davis SC; Ricotti C; Cazzaniga A; Welsh E; Eaglstein WH; Mertz PM
    Wound Repair Regen; 2008; 16(1):23-9. PubMed ID: 18211576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008).
    Bell JM; Turnidge JD; Sader HS; Jones RN
    Pathology; 2010; 42(5):470-3. PubMed ID: 20632825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study.
    Haas W; Pillar CM; Torres M; Morris TW; Sahm DF
    Am J Ophthalmol; 2011 Oct; 152(4):567-574.e3. PubMed ID: 21652021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.
    Kresken M; Hafner D; Schmitz FJ; Wichelhaus TA;
    Int J Antimicrob Agents; 2004 Jun; 23(6):577-81. PubMed ID: 15194128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
    Gales AC; Jones RN; Sader HS
    Clin Microbiol Infect; 2006 Apr; 12(4):315-21. PubMed ID: 16524407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clearance of nasal Staphylococcus aureus colonization with triple antibiotic ointment.
    Grossman EM; Nanda S; Gordon JR; Dubina M; Rademaker AW; West DP; Lio PA
    J Drugs Dermatol; 2012 Dec; 11(12):1490-2. PubMed ID: 23377521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
    Fritsche TR; Rhomberg PR; Sader HS; Jones RN
    J Antimicrob Chemother; 2008 May; 61(5):1092-8. PubMed ID: 18310135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997: Frequency of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Pfaller MA; Jones RN; Doern GV; Gales AC; Winokur PL; Kugler KC
    Braz J Infect Dis; 1999 Jun; 3(3):97-110. PubMed ID: 11097713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis.
    Sueke H; Kaye S; Neal T; Murphy C; Hall A; Whittaker D; Tuft S; Parry C
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2519-24. PubMed ID: 20019362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report.
    Orrett FA
    Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
    Fawley WN; Parnell P; Hall J; Wilcox MH
    J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.